<DOC>
	<DOCNO>NCT00842192</DOCNO>
	<brief_summary>This study conduct Asia . The aim observational study investigate safety efficacy insulin detemir add-on therapy type 2 diabetic patient use oral antidiabetic drug .</brief_summary>
	<brief_title>An Observational Study Type 2 Diabetic Patients Oral Antidiabetic Drugs Basal Insulin Near East Countries</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>After physician decision make use insulin detemir therapy , subject Type 2 diabetes treat one oral antidiabetic drug ( metformin , SU , repaglinide , TZDs ) eligible study . The selection subject discretion individual physician . Particular attention pay drug interaction list within product label Subjects currently treat insulin detemir insulin regimen include regular ( bolus ) insulin Subjects hypersensitivity insulin detemir excipients Women pregnant , breast feeding intention become pregnant within next 6 month . Women childbearing potential use adequate contraceptive method</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>